Susceptibility of Drug Resistant Hepatitis B Virus Mutants to Besifovir

Currently, interferon alpha and nucleos(t)ide analogues (NAs) are clinically available to treat hepatitis B virus (HBV) infection. Several NAs, including lamivudine (LMV), adefovir (ADV), entecavir (ETV) and tenofovir (TDF or TAF) have been approved and administered to chronic hepatitis B (CHB) pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Won, Juhee, Lee, Ah Ram, Dezhbord, Mehrangiz, Lee, Da Rae, Kim, Seong Ho, Kim, Jong Chul, Park, Soree, Kim, Nayeon, Jae, Byengjune, Kim, Kyun-Hwan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9312910/
https://www.ncbi.nlm.nih.gov/pubmed/35884942
http://dx.doi.org/10.3390/biomedicines10071637

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9312910/
https://www.ncbi.nlm.nih.gov/pubmed/35884942
http://dx.doi.org/10.3390/biomedicines10071637

Ejemplares similares